.Regeneron is back along with lasting follow-up for its LAG-3 prevention and PD-1 inhibitor combo in...
.AstraZeneca has shared a very early consider the functionality of its own internal antibody-drug co...
.After revealing a period 3 launch based upon favorable midstage end results, iTeos and GSK are even...
.The FDA must be much more available as well as collaborative to let loose a rise in approvals of ra...
.It is actually an uncommonly active Friday for biotech IPOs, with Zenas BioPharma, MBX and Bicara R...
.Atea Pharmaceuticals' antiviral has stopped working another COVID-19 test, yet the biotech still ke...
.Neurocrine Biosciences' mental illness plan pivot has neglected. The biotech was actually not able ...
.Sanofi has made a late entrance to the radioligand gathering, spending 100 thousand europeans ($ 11...
.After F2G's 1st try to get a new course of antifungal to market was wrecked by the FDA, the U.K.-ba...
.Moderna has vowed to reduce R&D costs through $1.1 billion through 2027. The choice to retract t...